促销时间表 Achieve Life Sciences, Inc.
先进的时间表
简单图表
关于公司 Achieve Life Sciences, Inc.
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc. is based in Vancouver, Canada.| IPO date | 1995-10-13 |
|---|---|
| ISIN | US0044685008 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | https://www.achievelifesciences.com |
| Цена ао | 4.66 |
| 每日价格变化: | -4.21% (3.8) |
|---|---|
| 每周价格变化: | -1.36% (3.69) |
| 每月价格变化: | -18.93% (4.49) |
| 3个月内价格变化: | -23.69% (4.77) |
| 六个月内的价格变化: | -20.7% (4.59) |
| 每年价格变化: | -11.65% (4.12) |
| 3年内价格变化: | -50.74% (7.39) |
| 5年内价格变化: | +292.45% (0.9275) |
| 10年价格变化: | 0% (3.64) |
| 年初以来价格变化: | -23.21% (4.74) |
|
|
低估
|
效率
|
|||||||||||||||||||||||||||||||||||||
股息
|
责任
|
成长冲动
|
|||||||||||||||||||||||||||||||||||||
| 机构 | 体积 | 分享, % |
|---|---|---|
| Shay Capital LLC | 725000 | 2.12 |
| Vanguard Group Inc | 605710 | 1.77 |
| Long Focus Capital Management, LLC | 248099 | 0.72 |
| Geode Capital Management, LLC | 184925 | 0.54 |
| LPL Financial LLC | 178500 | 0.52 |
| Raymond James & Associates, Inc. | 154829 | 0.45 |
| Northern Trust Corporation | 101984 | 0.3 |
| Walleye Capital LLC | 82599 | 0.24 |
| Wells Fargo & Company | 69891 | 0.2 |
| J. Goldman & Co., L.P. | 67501 | 0.2 |
| ETF | 分享, % | 本年盈利能力, % | 股息, % |
|---|---|---|---|
| iShares Micro-Cap ETF | 0.03998 | 17.09 | 1.54048 |
| Vanguard Russell 2000 Growth ETF | 0.01 | 23.05 | 0.60264 |
| Vanguard Russell 2000 ETF | 0.01 | 17.16 | 1.48801 |
iShares Russell 2000 Growth ETF
|
0.00703 | 38.04 | 0.6026 |
ProShares UltraPro Russell2000
|
0.00342 | 89.82 | 1.47873 |
| ProShares Hedge Replication ETF | 0.00092 | 5.92 | 1.47892 |
| Vanguard Russell 3000 ETF | 0 | 31.87 | 1.43817 |
| 导师 | 职称 | 支付 | 出生年份 |
|---|---|---|---|
| Dr. Richard A. B. Stewart | CEO & Executive Director | 663.75k | 1959 (66 年) |
| Dr. Cindy Jacobs M.D., Ph.D. | President, Chief Medical Officer & Director | 652.74k | 1958 (67 年) |
| Mr. Jerry Wan | Principal Accounting Officer | N/A | 1982 (43 年) |
| Ms. Jaime Xinos | Executive Vice President of Commercial | N/A | |
| Dr. Anthony Clarke Ph.D. | Chief Scientific Officer | 546k | 1956 (69 年) |
| Mr. Thomas B. King M.B.A. | Executive Chairman | 1955 (70 年) |
地址: Canada, Vancouver. BC VE H, 1040 West Georgia Street - 在 Google 地图中打开, 打开 Yandex 地图
网站: https://www.achievelifesciences.com
网站: https://www.achievelifesciences.com
